Evaluation of hypereosinophilia in FLT3-ITD AML
We used a targeted gene panel to evaluate the origin of of mature leukocytes in a patient with AML treated with a FLT3 inhibitor. Sequencing was performed on bone marrow aspirates, peripheral blood, and fractionated leukocytes. Each specimen was run on 4 lanes with paired end reads.